Hospira Hits New 52-Week High at $48.41 (HSP)
Hospira (NYSE:HSP) shares reached a new 52-week high during trading on Tuesday , Analyst Ratings News reports. The company traded as high as $48.41 and last traded at $48.00, with a volume of 326,443 shares trading hands. The stock had previously closed at $47.98.
HSP has been the subject of a number of recent research reports. Analysts at Leerink Swann reiterated a “market perform” rating on shares of Hospira in a research note on Thursday, May 1st. They now have a $48.00 price target on the stock. Separately, analysts at Citigroup Inc. reiterated a “sell” rating on shares of Hospira in a research note on Thursday, May 1st. They now have a $35.00 price target on the stock. Finally, analysts at Stifel Nicolaus initiated coverage on shares of Hospira in a research note on Thursday, April 17th. They set a “neutral” rating on the stock. One analyst has rated the stock with a sell rating and six have issued a hold rating to the stock. Hospira presently has a consensus rating of “Hold” and an average price target of $42.43.
The stock has a 50-day moving average of $45.44 and a 200-day moving average of $42.78. The company has a market cap of $8.020 billion and a P/E ratio of 59.09.
Hospira (NYSE:HSP) last posted its quarterly earnings results on Wednesday, April 30th. The company reported $0.60 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.49 by $0.11. The company had revenue of $1.10 billion for the quarter, compared to the consensus estimate of $1.02 billion. During the same quarter in the previous year, the company posted $0.52 earnings per share. The company’s revenue for the quarter was up 6.3% on a year-over-year basis. On average, analysts predict that Hospira will post $2.19 earnings per share for the current fiscal year.
In other Hospira news, CFO Thomas Werner sold 30,000 shares of the stock on the open market in a transaction dated Wednesday, May 21st. The stock was sold at an average price of $47.98, for a total value of $1,439,400.00. Following the sale, the chief financial officer now directly owns 54,614 shares of the company’s stock, valued at approximately $2,620,380. The sale was disclosed in a legal filing with the SEC, which is available at this link.
Hospira, Inc (NYSE:HSP) is a provider of injectable drugs and infusion technologies.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.